ARCHIVES

Gleevec Approval Sets Record For FDA Review: 73 Days

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

DCBD Board Approves Recompetition Concepts, Including Cell Banks, Contrast Agents, Hepatoma Resources

November 14, 1980

Siemens To Provide Technology To DxTx For Lung Cancer Detection.

December 14, 2001

PRI Asks NIH To Cancel Recompetition Of Frederick Center Operations Contract

February 17, 1995

NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.

December 1, 2000

Schweiker Approves Chabner Appointment

September 10, 1982

DOD funds $4.2 million gynecologic oncology research program at four institutions.

July 2, 2004